Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Cash from Operations (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Cash from Operations data on record, last reported at 36167000.0 in Q3 2025.

  • For Q3 2025, Cash from Operations fell 12.91% year-over-year to 36167000.0; the TTM value through Sep 2025 reached 158433000.0, down 11128.42%, while the annual FY2024 figure was 3468000.0, 97.82% up from the prior year.
  • Cash from Operations reached 36167000.0 in Q3 2025 per GOSS's latest filing, up from 47061000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 116348000.0 in Q2 2024 and bottomed at 53483000.0 in Q1 2022.
  • Average Cash from Operations over 4 years is 31507333.33, with a median of 38251000.0 recorded in 2023.
  • Peak YoY movement for Cash from Operations: soared 404.17% in 2024, then tumbled 140.45% in 2025.
  • A 4-year view of Cash from Operations shows it stood at 47730000.0 in 2022, then grew by 29.97% to 33424000.0 in 2023, then fell by 6.15% to 35481000.0 in 2024, then dropped by 1.93% to 36167000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 36167000.0 in Q3 2025, 47061000.0 in Q2 2025, and 39724000.0 in Q1 2025.